Dr. Kirk Robert Schott, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20312 Highway M-28 West, Suite C, Ewen, MI 49925 Phone: 906-988-2752 Fax: 906-988-2753 |
Kirk Robert Schott Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20312 State Highway M28, Suite C, Ewen, MI 49925 Phone: 906-988-2752 Fax: 906-988-2753 |
News Archive
Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018.
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
Janssen Inc. has filed a New Drug Submission (NDS) to Health Canada for the investigational drug abiraterone acetate administered with prednisone for the treatment of metastatic, advanced prostate cancer in patients who have received prior chemotherapy containing a taxane. Submissions for abiraterone acetate have also been filed with health authorities in the United States and Europe.
The U.S. Food and Drug Administration has cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria, a mosquito-borne disease caused by a parasite. The test is intended for laboratory use.
› Verified 6 days ago